1270621

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 20, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)